Lobbyist Public Search

Records prior to registration year 2005 are not available online. Contact the Lobbyist Division here for assistance.	Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
	Your comments are welcome: submit feedback

Disclosure reporting details

Back to search detail summary

Lobbyist disclosure reporting period: 07/01/2024 - 12/31/2024

Operating Expenses

No operating expenses were filed for this disclosure reporting period.

Activities, Bill Numbers and Titles

Client: Biogen Inc.

Total amount paid by client; lobbyist is unable to report compensation at activity level: $1,990.50

House / Senate	Bill Number or Agency Name	Bill title or activity	Agent position	Amount	Direct business association
House Bill	1074	An Act relative to cancer patient access to biomarker testing to provide appropriate therapy	Support	$0.00	N/A
Senate Bill	2499	An Act relative to pharmaceutical access, costs and transparency	Oppose	$0.00	N/A
Senate Bill	689	An Act relative to patient access to biomarker testing to provide appropriate therapy	Support	$0.00	N/A
Senate Bill	612	An Act relative to promoting healthcare access and affordability for patients	Support	$0.00	N/A
House Bill	978	An Act relative to promoting healthcare access and affordability for patients	Support	$0.00	N/A
Senate Bill	631	An Act relative to access to care for serious mental illness	Support	$0.00	N/A
House Bill	984	An Act relative to access to care for serious mental illness	Oppose	$0.00	N/A
Senate Bill	2520	An Act relative to pharmaceutical access, costs and transparency	Oppose	$0.00	N/A
Senate Bill	609	An Act relative to consumer deductibles	Support	$0.00	N/A
House Bill	4910	An Act promoting access and affordability of prescription drugs	Support	$0.00	N/A
House Bill	1176	An Act relative to promoting comprehensive transparency in the pharmaceutical industry	Support	$0.00	N/A
House Bill	945	An Act to ensure prescription drug cost transparency and affordability	Oppose	$0.00	N/A
			Total amount	$0.00

Meals, Travel, and Entertainment Expenses

No meals, travel, or entertainment expenses were filed for this disclosure reporting period.

Additional Expenses

No additional expenses were filed for this disclosure reporting period.

Campaign Contributions

Date	Recipient name	Office sought	Amount
11/18/2024	Kim Driscoll	Lieutenant Governor	$25.00
		Total contributions	$25.00